Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3199
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00069589 | Alopecia Areata Registry | ||
| NCT04848974 | Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia | ||
| NCT01955460 | Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma | ||
| NCT02782403 | Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia | ||
| NCT04940286 | Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer | ||
| NCT02255773 | Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral Measures | ||
| NCT00038168 | Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | ||
| NCT07283679 | Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma | ||
| NCT03283046 | Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT01492673 | Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma | ||
| NCT03455608 | PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer | ||
| NCT00761397 | Adherence to Swallowing Exercises in Head and Neck Cancer | ||
| NCT06966050 | Multi-center MRD Registry for Inflammatory Breast Cancer | ||
| NCT00367224 | Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo | ||
| NCT06113289 | A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia | ||
| NCT04513990 | Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) | ||
| NCT04236882 | Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African Americans | ||
| NCT01038635 | 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) | ||
| NCT01952860 | Hatha Yoga in Lung Cancer Couples | ||
| NCT00500942 | Pain Quantification and Pain Management in Interventional Radiology (IR) | ||
| NCT04810091 | Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor | ||
| NCT00924820 | A Pilot Study of Bevacizumab for Neoplastic Meningitis | ||
| NCT06872723 | CPRIT: Patient Adherence to Lung Cancer Screening | ||
| NCT04095923 | A Social Media Game to Increase Physical Activity Among Older Adult Women | ||
| NCT05776979 | Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients | ||
| NCT01603303 | Preventing Sexual Dysfunction With Aromatase Inhibitors | ||
| NCT01365169 | Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" | ||
| NCT02042950 | A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma | ||
| NCT00493467 | Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas | ||
| NCT00350818 | Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) | ||
| NCT05922943 | Harmony & Health: A Culturally Adapted Mindbody Intervention to Reduce Sitting Time and Improve Psychosocial Wellbeing in Black Adults | ||
| NCT01317550 | A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil | ||
| NCT01787474 | Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT00566618 | Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis | ||
| NCT03578484 | Breast Aesthetics by Three Dimensional Measures | ||
| NCT04132843 | Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions | ||
| NCT00514189 | Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines | ||
| NCT06826768 | A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC | ||
| NCT00038792 | Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD | ||
| NCT00837239 | Huachansu & Gemcitabine in Pancreatic Cancer | ||
| NCT00827801 | M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program | ||
| NCT03989466 | Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia | ||
| NCT04488081 | I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients | ||
| NCT06445907 | Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT00749892 | Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer | ||
| NCT04219969 | FDG PET-MRI for the Diagnosis of Spinal Cord Lesions | ||
| NCT00778375 | Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) | ||
| NCT01703195 | Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina | ||
| NCT06358430 | Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) | ||
| NCT04708054 | Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS |
